VCYT (STOCKS)
Veracyte, Inc.
$32.440000
+1.350000 (+4.34%)
Prev close: $31.090000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Marc A. Stapley
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,577.63M
- Employees
- 824
- P/E (TTM)
- 37.75
- P/B (TTM)
- 1.88
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
8
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$0.51 | $0.22 | +0.2907 | +132.56% |
|
Sep 2025 (Q3)
|
$0.24 | $0.13 | +0.1059 | +78.97% |
|
Jun 2025 (Q2)
|
$-0.01 | $0.10 | -0.1069 | -110.32% |
|
Mar 2025 (Q1)
|
$0.09 | $0.05 | +0.0377 | +72.08% |
Financial Statements
| Revenues | $517.15M |
| Benefits Costs and Expenses | $448.94M |
| Cost Of Revenue | $154.61M |
| Costs And Expenses | $304.76M |
| Gross Profit | $362.53M |
| Operating Expenses | $304.76M |
| Research and Development | $70.81M |
| Other Operating Expenses | $233.94M |
| Operating Income/Loss | $57.78M |
| Income/Loss From Continuing Operations After Tax | $66.35M |
| Income/Loss From Continuing Operations Before Tax | $68.20M |
| Income Tax Expense/Benefit | $1.85M |
| Income Tax Expense/Benefit, Current | $2.43M |
| Income Tax Expense/Benefit, Deferred | -$580.00K |
| Net Income/Loss | $66.35M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $66.35M |
| Net Income/Loss Available To Common Stockholders, Basic | $66.35M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.84 |
| Diluted Earnings Per Share | $0.82 |
| Basic Average Shares | 78,584,291 |
| Diluted Average Shares | 80,573,140 |
| Assets | $1.41B |
| Current Assets | $488.38M |
| Inventory | $20.55M |
| Other Current Assets | $467.83M |
| Noncurrent Assets | $917.64M |
| Intangible Assets | $89.15M |
| Other Non-current Assets | $828.50M |
| Liabilities | $96.44M |
| Current Liabilities | $59.94M |
| Accounts Payable | $4.59M |
| Wages | $27.46M |
| Other Current Liabilities | $27.89M |
| Noncurrent Liabilities | $36.51M |
| Equity | $1.31B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.31B |
| Liabilities And Equity | $1.41B |
| Net Cash Flow From Operating Activities | $136.31M |
| Net Cash Flow From Operating Activities, Continuing | $136.31M |
| Net Cash Flow From Investing Activities | -$9.21M |
| Net Cash Flow From Investing Activities, Continuing | -$9.21M |
| Net Cash Flow From Financing Activities | -$4.22M |
| Net Cash Flow From Financing Activities, Continuing | -$4.22M |
| Exchange Gains/Losses | $719.00K |
| Net Cash Flow | $123.60M |
| Net Cash Flow, Continuing | $122.88M |
| Comprehensive Income/Loss | $94.23M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $94.23M |
| Other Comprehensive Income/Loss | $94.23M |
| Other Comprehensive Income/Loss Attributable To Parent | $27.88M |